Moreover, the National Comprehensive Cancer Network (NCCN) guidelines for hereditary BC genetic risk assessment recommends genetic evaluation of the ATM, CHEK2, NBN, NF1, and PALB2 genes beside the BRCA1/2 genes [18]. The gene discussed is PALB2; the disease is breast cancer.